At Swiss Medica, parents observe changes in: Learning readiness: ability to focus, shift attention, and stay with an activity Communication attempts: use of words, AAC devices, gestures, or eye contact Emotional regulation: frequency and intensity of meltdowns, recovery time Sleep patterns: time needed to fall asleep, night waking Participation in routines: engagement in meals, play, school tasks, and self-care In our clinical practice, we observe these improvements in approximately 80% of patients , ranging from minor changes to more significant outcomes
The science of Microdosing GLP-1 Broad clinical potential: Commonly used to treat type 2 diabetes and weight management, GLP-1 medications act on GLP-1 receptors located in the brain, gut, and immune system, impacting multiple biomarkers. Recent studies have begun exploring low doses of GLP-1 medications for broader health goals beyond glucose control and weight loss. Emerging research in healthspan and longevity: In a series of studies, low doses of GLP-1 receptor agonists were shown to modulate inflammatory pathways, support mitochondrial function, and lower the risk of cognitive decline in study participantsgiving Microdosing GLP-1 promising potential for extending healthspan
No Session Length 15 minutes # of Sessions Needed Varies Results Duration Varies Shot Bar Menu Wellness Shots and Cocktails From caffeine and cold weather to sunlight, pollution, and yeshangovers
The world of peptides for weight loss continues to evolve
